Journals / Journal of Cellular Neuroscience and Oxidative Stress / 2019 / Cilt: 11 - Sayı: 3

IDH1 R132H gene mutation reduces cell proliferation and sensitizes recurrent Glioblastoma to hydrogen peroxide

Pages
895–902
Publication Date
2020-04-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

IDH1 R132H gene mutation significantly reduced the growth rate and sensitized the GBM cells to hydrogen peroxide at 72 hours (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Glioblastoma (GBM) recurrence rate is 90% resulting in 15 months median survival only.
📊
Key Findings & Data:Isocitrate dehydrogenase 1 (IDH1) mutations in gliomas significantly improved patient’s prognosis.
💡
Conclusion & Impact:IDH1 R132H gene mutation significantly reduced the growth rate and sensitized the GBM cells to hydrogen peroxide at 72 hours (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Glioblastoma · IDH1 R132H · Proliferation rate

Abstract

Glioblastoma (GBM) recurrence rate is 90% resulting in 15 months median survival only. Isocitrate dehydrogenase 1 (IDH1) mutations in gliomas significantly improved patient’s prognosis. Therefore, understanding common IDH1 mutation, IDH1 R132H in recurrent GBM is necessary to improve poor survival rate. IDH1 R132H recurrent GBM was developed to investigate cell proliferation rate and sensitivity towards oxidative stress induced by hydrogen peroxide. The cell death mechanism induced by hydrogen peroxide were further investigated. Malaysian recurrent GBM cell line was authenticated via Short Tandem Repeat and screened for IDH1 gene via PCR. IDH1 R132H gene expression in GBM was confirmed via real-time PCR and western blot. The effect of IDH1 R132H mutation on cell proliferation rate and cytotoxicity using hydrogen peroxide were determined using MTT assay. The angiogenesis, apoptotic genes and cell cycle induced by hydrogen peroxide in IDH1 wild-type GBM were determined via real-time PCR and flow-cytometry. Malaysian GBM cell line is unique and harbors IDH1 wild-type gene. IDH1 R132H gene mutation significantly reduced the growth rate and sensitized the GBM cells to hydrogen peroxide at 72 hours (p

🔖

Cite This Article

GOH, W. C., SHAMSUDDIN, S., IDRIS, B., IDRIS, Z., AHMAD, F. (2020). IDH1 R132H gene mutation reduces cell proliferation and sensitizes recurrent Glioblastoma to hydrogen peroxide. Journal of Cellular Neuroscience and Oxidative Stress, Cilt: 11 - Sayı: 3, 895–902. https://ajindex.com/articles/827256

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Agarwal S, Sharma MC, Jha P, Pathak P, Suri V. 2013. Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing. Neuro. Oncol. 15(6):718–26
  2. Ayyagari VN, Diaz-Sylvester PL, Hsieh THJ, Brard L. 2017. Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines. PLoS One. 12(9):e0185111 Bhattacharya S. 2015. Reactive Oxygen Species and Cellular Defense System. Free Radicals Hum. Heal. Dis. 17–29
  3. Boisselier B, Marie Y, Labussière M, Ciccarino P, Desestret V, et al. 2010. COLD PCR HRM: A highly sensitive detection method for IDH1 mutations. Hum. Mutat. 31(12):1360–65
  4. Fofaria NM, Kim S, Srivastava SK. 2014. Piperine Causes G1 Phase Cell Cycle Arrest and Apoptosis in Melanoma Cells through Checkpoint Kinase-1 Activation. PLoS One. 9(5):1–10
  5. Fu Y, Zheng S, Zheng Y, Huang R, An N, et al. 2012. Glioma derived isocitrate dehydrogenase-2 mutations induced up-regulation of HIF-1α and β-catenin signaling: Possible impact on glioma cell metastasis and chemo-resistance. Int. J. Biochem. Cell Biol. 44(5):770–75
  6. Goh CH, Lu YY, Lau BL, Wong JOL, Lee HK, et al. 2014. Brain and spinal tumour. Med. J. Malaysia. 69(6):261–67
  7. Goh WC, Idris B, Kandasamy R, Shamsuddin S, Jaafar H. 2019. PCR-RFLP method enhance DNA sequencing of IDH1 somatic mutations detection in gliomas. Gulhane Med. J. 61(4):167–71
  8. Gupta R, Flanagan S, Li CC, Lee M, Shivalingham B, et al. 2013. Expanding the spectrum of IDH1 mutations in gliomas. Mod. Pathol. 26(5):619–25
  9. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, et al. 2009. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1,010 diffuse gliomas. Acta Neuropathol. 118(4):469–74
  10. Horbinski C, Kelly L, Nikiforov YE, Durso MB, Nikiforova MN. 2010. Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies. J. Mol. Diagnostics. 12(4):487–92
  11. Lau D, Magill ST, Aghi MK. 2014. Molecularly targeted therapies for recurrent glioblastoma: Current and future targets. Neurosurg. Focus. 37(6): Li S, Chou AP, Chen W, Chen R, Deng Y, et al. 2013. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. Neuro. Oncol. 15(1):57–68 Lopez-Lazaro M. 2007. Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy. Cancer Lett. 252:1–8
  12. Loussouarn D, Le Loupp AG, Frene